UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 133

Sortiert nach

Preclinical modeling of myelodysplastic syndromes

Leukemia, 2017-12, Vol.31 (12), p.2702-2708

2017

Volltextzugriff (PDF)

Les lumières de la guerre, Volume 1: Mémoires militaires du XVIIIe siècle conservés au service historique de la Défense (Sous-série 1 - Mémoires techniques)

2015

Volltextzugriff (PDF)

Les dernières guerres de Louis XIV: 1688-1715

2017

Volltextzugriff (PDF)

Use of the 46/1 haplotype to model JAK2(V617F) clonal architecture in PV patients: clonal evolution and impact of IFNα treatment

Leukemia, 2014-02, Vol.28 (2), p.460-463

2014

Volltextzugriff (PDF)

La durée de vie des plaquettes autologues marquées à l’oxinate d’indium-111 est interprétable chez les patients avec un PTI chronique traités par agonistes du récepteur de la thrombopoiëtine

La revue de medecine interne, 2016-12, Vol.37, p.A137-A137

2016

Volltextzugriff (PDF)

Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?

Clinical cancer research, 1997-12, Vol.3 (12), p.2451-2458

1997

Volltextzugriff (PDF)

Advanced glycation end products, oxidant stress and vascular lesions

European journal of clinical investigation, 1997-02, Vol.27 (2), p.97-108

1997

Volltextzugriff (PDF)

Strong association between plasma thrombomodulin and pathergy test in Behçet disease

Annals of the rheumatic diseases, 2008-06, Vol.67 (6), p.892-893

2008

Volltextzugriff (PDF)

Does increasing the JAK2V617F assay sensitivity allow to identify more patients with MPN?

Blood cancer journal (New York), 2012-05, Vol.2 (5), p.e70-e70

2012

Volltextzugriff (PDF)

Eruptive angiomatous lesions associated with graft-versus-host disease

British journal of dermatology (1951), 2003-09, Vol.149 (3), p.667-668

2003

Volltextzugriff (PDF)

OC 46.3 JAK2V617F-Positive Myeloproliferative Neoplasms are Associated with Impaired Fibrinolysis Both in Mice and Humans

Research and practice in thrombosis and haemostasis, 2023-10, Vol.7, p.100610, Article 100610

2023

Volltextzugriff (PDF)

Randomized trial and local biological effect of autologous platelets used as adjuvant therapy for chronic venous leg ulcers

Journal of vascular surgery, 2003-12, Vol.38 (6), p.1342-1348

2003

Volltextzugriff (PDF)

Phase I study of high-dose topotecan with haematopoietic stem cell support in the treatment of ovarian carcinomas: the ITOV 01 protocol

Bone marrow transplantation (Basingstoke), 2006-04, Vol.37 (7), p.669-675

2006

Volltextzugriff (PDF)

Clinical phase I and pharmacokinetic study of S 16020, a new olivacine derivative: report on three infusion schedules

Annals of oncology, 2002-12, Vol.13 (12), p.1925-1934

2002

Volltextzugriff (PDF)

Tissue engineering for full-thickness burns: A dermal substitute from bench to bedside

Biochemical and biophysical research communications, 2007-11, Vol.363 (3), p.472-478

2007

Volltextzugriff (PDF)

EBV transformation of cells from cord blood donations: relevance to future retrospective studies on cord blood transplants

Bone marrow transplantation (Basingstoke), 2005-03, Vol.35 (6), p.619-621

2005

Volltextzugriff (PDF)

S1610 MASKED POLYCYTHEMIA VERA: ANALYSIS OF A SINGLE CENTER SERIES OF 2480 RED CELL MASSES

HemaSphere, 2019-06, Vol.3 (S1), p.742-n/a

2019

Volltextzugriff (PDF)

Effects of platelet lysates on select bone cell functions

Clinical oral implants research, 2004-10, Vol.15 (5), p.581-588

2004

Volltextzugriff (PDF)

Biomarqueurs aux phases précoces de développement dans la maladie d’Alzheimer

Therapie, 2010-07, Vol.65 (4), p.277-283

2010

Volltextzugriff (PDF)

Use of the 46/1 haplotype to model [JAK2.sup.V617F] clonal architecture in PV patients: clonal evolution and impact of IFNα treatment

Leukemia, 2014-02, Vol.28 (2), p.460

2014

Volltextzugriff (PDF)

Use of the 46/1 haplotype to model JAK2 super(V617F) clonal architecture in PV patients: clonal evolution and impact of IFN alpha treatment

Leukemia, 2014-02, Vol.28 (2), p.460-463

2014

Volltextzugriff (PDF)

Use of the 46/1 haplotype to model JAK2V617F clonal architecture in PV patients: clonal evolution and impact of IFN[alpha] treatment

Leukemia, 2014-02, Vol.28 (2), p.460

2014

Volltextzugriff (PDF)

Protective Effects of Basic Fibroblast Growth Factor in Early Atherosclerosis

Growth factors (Chur, Switzerland), 2004-09, Vol.22 (3), p.157-167

2004

Volltextzugriff (PDF)

Self‐Healing Generalized Infantile Myofibromatosis with Elevated Urinary bFGF

Pediatric dermatology, 2001-07, Vol.18 (4), p.305-307

2001

Volltextzugriff (PDF)

Use of the 46/1 haplotype to model JAK2V617F clonal architecture in PV patients: clonal evolution and impact of IFNα treatment

Leukemia, 2014-02, Vol.28 (2), p.460-463

2014

Volltextzugriff (PDF)

1 – 25 von 133

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(95)
Mit Volltextzugriff
(94)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Preclinical modeling of myelodysplastic syndromes

Les lumières de la guerre, Volume 1: Mémoires militaires du XVIIIe siècle conservés au service historique de la Défense (Sous-série 1 - Mémoires techniques)

Les dernières guerres de Louis XIV: 1688-1715

Use of the 46/1 haplotype to model JAK2(V617F) clonal architecture in PV patients: clonal evolution and impact of IFNα treatment

La durée de vie des plaquettes autologues marquées à l’oxinate d’indium-111 est interprétable chez les patients avec un PTI chronique traités par agonistes du récepteur de la thrombopoiëtine

Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?

Advanced glycation end products, oxidant stress and vascular lesions

Strong association between plasma thrombomodulin and pathergy test in Behçet disease

Does increasing the JAK2V617F assay sensitivity allow to identify more patients with MPN?

Eruptive angiomatous lesions associated with graft-versus-host disease

OC 46.3 JAK2V617F-Positive Myeloproliferative Neoplasms are Associated with Impaired Fibrinolysis Both in Mice and Humans

Randomized trial and local biological effect of autologous platelets used as adjuvant therapy for chronic venous leg ulcers

Phase I study of high-dose topotecan with haematopoietic stem cell support in the treatment of ovarian carcinomas: the ITOV 01 protocol

Clinical phase I and pharmacokinetic study of S 16020, a new olivacine derivative: report on three infusion schedules

Tissue engineering for full-thickness burns: A dermal substitute from bench to bedside

EBV transformation of cells from cord blood donations: relevance to future retrospective studies on cord blood transplants

S1610 MASKED POLYCYTHEMIA VERA: ANALYSIS OF A SINGLE CENTER SERIES OF 2480 RED CELL MASSES

Effects of platelet lysates on select bone cell functions

Biomarqueurs aux phases précoces de développement dans la maladie d’Alzheimer

Use of the 46/1 haplotype to model [JAK2.sup.V617F] clonal architecture in PV patients: clonal evolution and impact of IFNα treatment

Use of the 46/1 haplotype to model JAK2 super(V617F) clonal architecture in PV patients: clonal evolution and impact of IFN alpha treatment

Use of the 46/1 haplotype to model JAK2V617F clonal architecture in PV patients: clonal evolution and impact of IFN[alpha] treatment

Protective Effects of Basic Fibroblast Growth Factor in Early Atherosclerosis

Self‐Healing Generalized Infantile Myofibromatosis with Elevated Urinary bFGF

Use of the 46/1 haplotype to model JAK2V617F clonal architecture in PV patients: clonal evolution and impact of IFNα treatment

Suchergebnisse filtern